Santen Pharmaceutical Co., Ltd. (TYO:4536)
1,748.00
+26.00 (1.51%)
Jan 22, 2026, 3:30 PM JST
Santen Pharmaceutical Market Cap
Santen Pharmaceutical has a market cap or net worth of 519.72 billion as of January 21, 2026. Its market cap has decreased by -2.66% in one year.
Market Cap
519.72B
Enterprise Value
455.00B
Revenue
291.48B
Ranking
n/a
PE Ratio
18.57
Stock Price
1,748.00
Market Cap Chart
Since January 14, 1992, Santen Pharmaceutical's market cap has increased from 150.82B to 519.72B, an increase of 244.60%. That is a compound annual growth rate of 3.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 519.72B | 5.90% |
| Dec 30, 2025 | 490.75B | -11.17% |
| Dec 30, 2024 | 552.48B | 8.00% |
| Dec 29, 2023 | 511.57B | 23.49% |
| Dec 30, 2022 | 414.25B | -26.39% |
| Dec 30, 2021 | 562.77B | -15.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 13.68T |
| Daiichi Sankyo Company | 5.89T |
| Otsuka Holdings | 4.73T |
| Astellas Pharma | 3.96T |
| Kyowa Kirin | 1.36T |
| Ono Pharmaceutical | 1.05T |
| JCR Pharmaceuticals | 82.71B |
| Perseus Proteomics | 3.75B |